GCL Technology: It is estimated that there will be no more share repurchase cancellation in 2024. GCL Technology (03800) announced that in view of the fact that the photovoltaic industry is still in excessive competition, in order to ensure the stability of the company's operation and cope with the uncertainty in the future, the company expects that there will be no more share repurchase cancellation in the year ending December 31, 2024.General Administration of Financial Supervision: Help boost consumer support and expand bulk consumption, service consumption and new consumption. The Party Committee of the State Financial Supervision and Administration held a meeting to convey the spirit of studying the Central Economic Work Conference. The meeting requested that the real economy should be better served to help boost consumption and support the expansion of bulk consumption, service consumption and new consumption. Strengthen the financing guarantee for investment and effectively serve the "double" and "two new". Expand the pilot of equity investment of financial asset investment companies in an orderly manner. Do a solid job in supporting the financing coordination mechanism of small and micro enterprises. Increase financial support for foreign trade enterprises and strengthen export credit insurance and credit services. Actively guide banks and insurance institutions to reduce costs and increase efficiency, broaden capital replenishment channels, and improve their sustainable development capabilities. Promote high-level financial openness with higher standards and greater efforts, and attract more foreign financial institutions and long-term capital to set up businesses in China.Hikvision: The controlling shareholder has obtained a commitment letter for a special loan of 120 million yuan to increase its holdings. Hikvision announced that the company recently received a notice from the controlling shareholder, CLP Hikvision, that CLP Hikvision has obtained a commitment letter for a special loan to increase its holdings issued by China Industrial and Commercial Bank of China. Hangzhou Branch of Industrial and Commercial Bank of China will provide a loan fund of no more than 120 million yuan for CLP Hikvision Group to increase its shareholding in Hikvision by centralized bidding, and the loan period will not exceed 3 years.
In November, the real effective interest rate of the Russian ruble decreased by 1.6% from the previous month.Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.The US import price index in November was 1.3% year-on-year, expected to be 1%, and the previous value was 0.8%. The annual export price index of the United States in November was 0.8%, expected to be 0.3%, and the previous value was-0.10%.
Bei Ya raised the Amazon target price from $220.00 to $260.00.Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.Two States in the United States sued Glock, a gun manufacturer, for ignoring the design flaw that "pistols can easily become machine guns". On the 12th, the prosecutors in New Jersey and Minnesota respectively sued Glock, an Austrian weapons manufacturer, accusing the pistol manufactured by them of design defects and being easily converted into illegal machine guns. According to the complaint, Glock knew this situation for a long time, and continued to sell this pistol to the United States and profit from it, which promoted the proliferation of gun violence in the United States. (Xinhua News Agency)
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14